Grimes & Company’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Hold
406,987
0.01% 390
2026
Q1
$362K Hold
406,987
0.01% 336
2025
Q4
$566K Hold
406,987
0.01% 298
2025
Q3
$810K Hold
406,987
0.02% 250
2025
Q2
$777K Buy
406,987
+187,226
+85% +$264K 0.02% 228
2025
Q1
$294K Hold
219,761
0.01% 295
2024
Q4
$349K Hold
219,761
0.01% 294
2024
Q3
$316K Hold
219,761
0.01% 281
2024
Q2
$422K Hold
219,761
0.01% 239
2024
Q1
$976K Hold
219,761
0.03% 181
2023
Q4
$683K Buy
+219,761
New +$825K 0.02% 198

Other funds holding SKIN

Grimes & Company's SKIN Position: Q2 2026 in Review

Grimes & Company held its SkinHealth Systems (SKIN) position steady in Q2 2026 at 406,987 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #390.

Grimes & Company first reported a position in SKIN in Q4 2023 and has held it in 11 quarters since. The position peaked at $976K in Q1 2024. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Grimes & Company held 406,987 shares of SkinHealth Systems worth $282K as of Q2 2026.
  • Grimes & Company left its SkinHealth Systems share count unchanged in Q2 2026.
  • SkinHealth Systems made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #390 holding.
  • Grimes & Company first reported a position in SkinHealth Systems in Q4 2023 and has held it in 11 quarters since.
  • Grimes & Company's SkinHealth Systems position peaked at $976K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.